Provider P52-15 Prior Authorization Requirements for a New Drug, Orkambi (lumacaftor/ivacaftor) Read More
Provider P50-16 Addition of a Drug (Xiidra) to the Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Read More
Provider P53-16 New Notification Requirement for Outpatient Dialysis Services for Commercial Products and Subscribers in Government Programs Read More
Provider P17-17 Addition of Drug Kisqali to the Self-Administered Oncology Prior Authorization with Quantity Limit Program Read More